Next in Pharma: The 2025 Outlook—The Future is Now скачать в хорошем качестве

Next in Pharma: The 2025 Outlook—The Future is Now

Tune in as PwC's Pharmaceutical & Life Sciences Advisory Leader, Greg Rotz reflects on key market dynamics and explores how pharma leaders can tackle challenges including the $400 billion patent cliff, increasing competition, drug pricing pressures, and transformative disruptions shaping the industry. Discussion highlights: • Understanding the scale and implications of the upcoming patent cliff and economic pressures from regulatory changes like the Inflation Reduction Act • Examining heightened competition across therapeutic areas and the rapid emergence of rival treatments affecting market economics • Highlighting the necessity for bold strategic moves and critical capabilities, including AI innovation, portfolio optimization, strategic partnerships, and comprehensive risk management • Addressing disruptive forces such as geopolitical uncertainty, tariff impacts, and the rise of global innovation influencing pharmaceutical markets • Emphasizing the urgency for pharma leaders to embrace innovation and transformative strategies to improve healthcare affordability, accessibility, and quality Speakers: Greg Rotz, Pharmaceutical & Life Sciences Leader,PwC Glenn Hunzinger, Health Industries Leader, PwC Jenny Colapietro, Consulting Commercial Leader, PwC Linked materials: Next in pharma 2025: The future is now (https://www.pwc.com/us/en/industries/...) Pharmaceutical and life sciences: US Deals 2025 outlook (https://www.pwc.com/us/en/industries/...) President Donald J. Trump’s healthcare agenda (https://www.pwc.com/us/en/industries/...) For more information, please visit us at: https://www.pwc.com/us/en/industries/....